Clinical Trial Update: Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating combination chemotherapy with trastuzumab in metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Trastuzumab (trastuzumab)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED